Immuneering (IMRX) Current Leases: 2020-2023
Historic Current Leases for Immuneering (IMRX) over the last 4 years, with Dec 2023 value amounting to $300,107.
- Immuneering's Current Leases rose 7.65% to $324,702 in Q3 2024 from the same period last year, while for Sep 2024 it was $324,702, marking a year-over-year increase of 7.65%. This contributed to the annual value of $300,107 for FY2023, which is 20.76% down from last year.
- Latest data reveals that Immuneering reported Current Leases of $300,107 as of FY2023, which was down 20.76% from $378,723 recorded in FY2022.
- In the past 5 years, Immuneering's Current Leases registered a high of $378,723 during FY2022, and its lowest value of $76,322 during FY2020.
- Moreover, its 3-year median value for Current Leases was $300,107 (2023), whereas its average is $317,623.
- As far as peak fluctuations go, Immuneering's Current Leases surged by 259.06% in 2021, and later decreased by 20.76% in 2023.
- Yearly analysis of 4 years shows Immuneering's Current Leases stood at $76,322 in 2020, then surged by 259.06% to $274,039 in 2021, then skyrocketed by 38.20% to $378,723 in 2022, then decreased by 20.76% to $300,107 in 2023.